Special Issue "Neuro-Ophthalmology and Optic Neuropathy"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 3392
As we know, retinal ganglion cells (RGCs) are the only neurons in the eye that transmit visual information to the brain via their extending axons in the optic nerve (ON). Optic neuropathies are conditions in which there is damage to the ON caused by a variety of causes, including glaucoma, inflammation, gene mutation, ischemia, trauma, and tumor. ON damage triggers a process of axon degeneration and the loss of retinal ganglion cells (RGCs), resulting in permanent vision loss. To date, several therapeutic strategies are purposed to regenerate axons or replace the RGC loss via neuroprotection, neuroregeneration, and neuronal replacement. This Special Issue is now open to receive manuscripts on all aspects of current and future strategies for RGC and ON protection, replacement, and regeneration. In this Special Issue, we welcome the submission of full reviews, original research, as well as perspectives that cover, but are not limited to, the following topics:
- Molecular mechanisms to protect RGCs and axons from damage.
- Ocular inflammation and RGC/axon degeneration.
- Stem-cell-based therapy to replace RGC loss.
- Gene therapy in optic neuropathies.
- Regenerative medicine in glaucoma and optic neuropathies.
- Neuroprotection for glaucomatous optic neuropathy.
Dr. Kun-Che Chang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- retinal ganglion cell
- axon regeneration
- optic neuropathy
- stem cell therapy
- gene therapy
- ocular inflammation